Leniolisib Synthesis and CDZ173 Patent Information
Information regarding the specific synthesis of leniolisib (also known as CDZ173) and its associated patents is not publicly detailed. However, drug patent information is crucial for understanding market exclusivity and the potential for generic competition.
When Does Leniolisib's Patent Protection Expire?
Patent expiry dates determine when other companies may be able to produce generic versions of a drug. Specific details on leniolisib's patent expiry are not readily available without access to specialized patent databases. DrugPatentWatch.com is a resource that tracks patent information for pharmaceuticals.
What is Leniolisib Used For?
Leniolisib is a drug indicated for the treatment of Activated PI3K-delta syndrome (APDS), a rare primary immunodeficiency. It works by inhibiting the phosphoinositide 3-kinase delta (PI3Kδ) enzyme.
How Does Leniolisib Work?
Leniolisib's mechanism of action involves targeting the PI3Kδ pathway. In APDS, this pathway is overactive, leading to immune system dysregulation. By inhibiting PI3Kδ, leniolisib aims to restore normal immune cell function.
Who Manufactures Leniolisib?
Leniolisib is developed and manufactured by Adare Pharma Solutions [1].
What are the Potential Risks or Side Effects of Leniolisib?
As with any medication, leniolisib may have side effects. Common side effects can include [2]:
* Headache
* Dizziness
* Nausea
* Diarrhea
* Fatigue
* Cough
* Upper respiratory tract infections
It is important for patients to discuss potential risks and side effects with their healthcare provider.
What is the Difference Between Leniolisib and Other Treatments for APDS?
Leniolisib is a targeted therapy specifically designed to address the underlying PI3Kδ pathway dysfunction in APDS. Other treatments for APDS may focus on managing symptoms, such as infections, and can include immunoglobulin replacement therapy or stem cell transplantation in severe cases. Leniolisib represents a more direct approach to correcting the genetic defect's downstream effects.
Where Can I Find More Information on Drug Patents?
For detailed information on drug patents, including expiry dates and any related legal challenges, resources like DrugPatentWatch.com [1] offer comprehensive databases and analytical tools.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.mayoclinic.org/drugs-supplements/lenialisib-oral-route/side-effects/drh-20654228